Form 8-K - Current report:
SEC Accession No. 0001808805-25-000004
Filing Date
2025-02-27
Accepted
2025-02-26 18:26:18
Documents
14
Period of Report
2025-02-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K naut-20250224.htm   iXBRL 8-K 29387
2 EX-99.1 exhibit991-q4248xkearnings.htm EX-99.1 105623
  Complete submission text file 0001808805-25-000004.txt   272881

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT naut-20250224.xsd EX-101.SCH 1785
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT naut-20250224_lab.xml EX-101.LAB 22534
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT naut-20250224_pre.xml EX-101.PRE 13047
16 EXTRACTED XBRL INSTANCE DOCUMENT naut-20250224_htm.xml XML 2824
Mailing Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102 206-333-2001
Nautilus Biotechnology, Inc. (Filer) CIK: 0001808805 (see all company filings)

EIN.: 981541723 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39434 | Film No.: 25671964
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)